pound 0.9 kilogram masses humans overnight angiogenesis inhibitors cancer therapy du jour beginning felt enormous pressure folkman said news raised expectations demand angiogenesis inhibitors drugs completed testing clinical trials new type therapy dilemma inform public early physicians besieged calls patients drugs not obtained late critics hope destroyed patients advanced disease antiangiogenic drugs mixed results human clinical trials past decade including 42 patients suffering cancers affecting hormone producing nerve cells given endostatin experienced long term relief today successful therapies involve angiogenesis early 2004 food drug administration fda approved avastin drug manufactured genentech use chemotherapy colorectal cancer antiangiogenic drug thalidomide okayed fda